This site and the material you have requested to view contain Novo Nordisk scientific materials presented at EHA 2022. The information on this site may relate to data concerning study drugs or therapeutic uses that have not been approved by drug regulatory agencies.
While there are no restrictions to view the site and/or material, please be aware of the following:
1. The information contained in this site is intended for non-US
healthcare professionals and provided for the purpose of scientific
exchange. It is not intended to promote in any way, any use, either
approved, or unapproved, of a Novo Nordisk product or of any other
product, or serve as basis for any decision or action.
2. Registration conditions vary internationally. Always refer to the
Summary of Product Characteristics (product label), as approved by
regulatory authorities in your country before prescribing.
3. Furthermore, it is not intended to replace the advice of a
healthcare professional and should not be construed as providing
advice or making a recommendation. The information on this site should
not be relied on as the basis for any decision or action. Only a
physician can determine whether a specific product is correct for a
particular patient. If you have any questions regarding any
information contained on this site you should consult a
4. Novo Nordisk accepts no liability for the accuracy, completeness
or use of this information, and disclaims any liability to update the
information contained on this site.
By accessing this site and materials you accept the legal notice for
Novo Nordisk scientific materials at EHA 2022.